TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value ($000): $252,020 (89.5% shares, 10.5% debt)

Holdings (5)

HRTX HERON THERAPEUTICS INC 55.0%

Value ($000) $138,595 Shares 5,190,837 Est. Cost $12.86 Unrealized +107.9%

— LA JOLLA PHARMACEUTICAL CO 30.8%

Value ($000) $77,548 Shares 2,872,130 Est. Cost $14.41 Unrealized —

— OPKO HEALTH INC 8.5%

Value ($000) $21,399 Shares 14,000,000 Est. Cost $1.47 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 3.8%

Value ($000) $9,451 Shares 90,215 Est. Cost $62.32 Unrealized +67.4%

— MERRIMACK PHARMACEUTICALS INC 2.0%

Value ($000) $5,027 Shares 3,500,000 Est. Cost $1.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	5,190,837	$138,595	55.0%	$12.86	+107.9%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	2,872,130	$77,548	30.8%	$14.41	—	COM	503459604
—	OPKO HEALTH INC	14,000,000	$21,399	8.5%	$1.47	—	DEBT 3.0% 2/1/33	68375NAB9
BMRN	BIOMARIN PHARMACEUTICAL INC	90,215	$9,451	3.8%	$62.32	+67.4%	COM	09061G101
—	MERRIMACK PHARMACEUTICALS INC	3,500,000	$5,027	2.0%	$1.36	—	NOTE 4.5% 7/15/20	590328AA8